HOMCY CHARLES J

CIK 000119259112 companiesPALO ALTO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001192591

Recent Transactions

50 trades

Award
BridgeBio Pharma, Inc.$BBIO
Common Stock
2026-06-22+3,990→ 919,876 total
Award
BridgeBio Pharma, Inc.$BBIO
Stock Option (Right to Buy)
2026-06-22+5,277→ 5,277 total
Tax Payment
BridgeBio Pharma, Inc.$BBIO
Common Stock
2026-06-20$66.27/sh−788→ 915,886 total
Award
Maze Therapeutics, Inc.$MAZE
Stock Option (Right to Buy)
2026-06-08+18,000→ 18,000 total
Gift
Maze Therapeutics, Inc.$MAZE
Common Stock
2026-05-04−7,422→ 31,113 total
Other
Maze Therapeutics, Inc.$MAZE
Common Stock
2025-11-19+1,489→ 31,113 total
Gift
Maze Therapeutics, Inc.$MAZE
Common Stock
2025-10-23−28,423→ 29,624 total
Award
Maze Therapeutics, Inc.$MAZE
Stock Option (Right to Buy)
2025-09-22+18,000→ 18,000 total
Sale
BridgeBio Pharma, Inc.$BBIO
Common Stock
2025-08-11$48.00/sh−50,000→ 916,674 total
Sale
BridgeBio Pharma, Inc.$BBIO
Common Stock
2025-08-08$46.64/sh−58,338→ 966,674 total
Sale
BridgeBio Pharma, Inc.$BBIO
Common Stock
2025-08-08$45.87/sh−191,662→ 1,025,012 total
Gift
BridgeBio Pharma, Inc.$BBIO
Common Stock
2025-06-27−20,000→ 1,216,674 total
Award
BridgeBio Pharma, Inc.$BBIO
Stock Option (Right to Buy)
2025-06-20+8,425→ 8,425 total
Award
BridgeBio Pharma, Inc.$BBIO
Common Stock
2025-06-20+6,589→ 1,236,674 total
Conversion
Maze Therapeutics, Inc.$MAZE
Series B Preferred Stock
2025-02-03−72,727→ 0 total
Conversion
Maze Therapeutics, Inc.$MAZE
Series C Preferred Stock
2025-02-03−169,405→ 0 total
Conversion
Maze Therapeutics, Inc.$MAZE
Series D-1 Preferred Stock
2025-02-03−71,564→ 0 total
Conversion
Maze Therapeutics, Inc.$MAZE
Common Stock
2025-02-03+20,717→ 58,047 total
Conversion
Maze Therapeutics, Inc.$MAZE
Common Stock
2025-02-03+8,807→ 37,330 total
Conversion
Maze Therapeutics, Inc.$MAZE
Common Stock
2025-02-03+7,422→ 7,422 total
Disposition to Issuer
Maze Therapeutics, Inc.$MAZE
Stock Option (Right to Buy)
2024-12-09−5,704→ 0 total
Award
Maze Therapeutics, Inc.$MAZE
Stock Option (Right to Buy)
2024-12-09+5,704→ 5,704 total
Disposition to Issuer
Maze Therapeutics, Inc.$MAZE
Stock Option (Right to Buy)
2024-12-09−80,385→ 0 total
Award
Maze Therapeutics, Inc.$MAZE
Stock Option (Right to Buy)
2024-12-09+45,638→ 45,638 total
Award
Maze Therapeutics, Inc.$MAZE
Stock Option (Right to Buy)
2024-12-09+46,675→ 46,675 total
Award
Maze Therapeutics, Inc.$MAZE
Stock Option (Right to Buy)
2024-12-09+80,385→ 80,385 total
Disposition to Issuer
Maze Therapeutics, Inc.$MAZE
Stock Option (Right to Buy)
2024-12-09−46,675→ 0 total
Conversion
Maze Therapeutics, Inc.$MAZE
8% Convertible Note due 2026
2024-11-26$78961.64/sh
Conversion
Maze Therapeutics, Inc.$MAZE
Series D-1 Preferred Stock
2024-11-26+71,564→ 7,422 total
Award
BridgeBio Pharma, Inc.$BBIO
Stock Option (Right to Buy)
2024-06-21+26,014→ 26,014 total
Exercise/Conversion
BridgeBio Pharma, Inc.$BBIO
Restricted Stock Units
2024-02-16−3,760→ 0 total
Tax Payment
BridgeBio Pharma, Inc.$BBIO
Common Stock
2024-02-16$37.21/sh−1,509→ 1,230,085 total
Exercise/Conversion
BridgeBio Pharma, Inc.$BBIO
Common Stock
2024-02-16+3,760→ 1,231,594 total
Exercise/Conversion
BridgeBio Pharma, Inc.$BBIO
Common Stock
2023-11-16+3,760→ 1,228,297 total
Exercise/Conversion
BridgeBio Pharma, Inc.$BBIO
Restricted Stock Units
2023-11-16−3,760→ 3,760 total
Tax Payment
BridgeBio Pharma, Inc.$BBIO
Common Stock
2023-11-16$28.86/sh−1,301→ 1,226,996 total
Exercise/Conversion
BridgeBio Pharma, Inc.$BBIO
Common Stock
2023-08-16+3,760→ 1,225,838 total
Exercise/Conversion
BridgeBio Pharma, Inc.$BBIO
Restricted Stock Units
2023-08-16−3,760→ 7,520 total
Tax Payment
BridgeBio Pharma, Inc.$BBIO
Common Stock
2023-08-16$29.80/sh−1,301→ 1,224,537 total
Award
BridgeBio Pharma, Inc.$BBIO
Stock Option (right to buy)
2023-06-21+51,501→ 51,501 total
Exercise/Conversion
BridgeBio Pharma, Inc.$BBIO
Restricted Stock Units
2023-05-16−3,759→ 11,280 total
Exercise/Conversion
BridgeBio Pharma, Inc.$BBIO
Common Stock
2023-05-16+3,759→ 1,222,127 total
Tax Payment
BridgeBio Pharma, Inc.$BBIO
Common Stock
2023-05-16$14.09/sh−1,300→ 1,220,827 total
Tax Payment
BridgeBio Pharma, Inc.$BBIO
Common Stock
2023-02-16$12.64/sh−1,534→ 1,218,368 total
Exercise/Conversion
BridgeBio Pharma, Inc.$BBIO
Common Stock
2023-02-16+3,760→ 1,219,902 total
Exercise/Conversion
BridgeBio Pharma, Inc.$BBIO
Restricted Stock Units
2023-02-16−3,760→ 15,039 total
Exercise/Conversion
BridgeBio Pharma, Inc.$BBIO
Restricted Stock Units
2022-11-16−3,760→ 18,799 total
Tax Payment
BridgeBio Pharma, Inc.$BBIO
Common Stock
2022-11-16$9.64/sh−1,301→ 1,214,251 total
Exercise/Conversion
BridgeBio Pharma, Inc.$BBIO
Common Stock
2022-11-16+3,760→ 1,215,552 total
Exercise/Conversion
BridgeBio Pharma, Inc.$BBIO
Restricted Stock Units
2022-08-16−3,760→ 22,559 total

HOMCY CHARLES J

Recent Transactions

Companies

Recent Filings

Address